Skip to main content

Table 4 Immunoglobulin class response patterns in MOG-IgG-positive EM

From: Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients

 

Units

Total

Attack

Remission

Acute MY subgroup

Acute ON subgroup

Acute BRAIN subgroup

a. Based on QIg > Qlim(Ig)

3-class reaction

Samples

3/63 (4.8%)

3/56 (5.4%)

0/5 (0%)

2/18 (11.1%)

0/16 (0%)

1/22 (4.5%)

2-class reaction

Samples

12/63 (19%)

12/56 (21.4%)

0/5 (0%)

6/18 (33.3%)

2/16 (12.5%)

4/22 (18.2%)

 IgG + IgM

Samples

2/63 (3.2%)

2/56 (3.6%)

0/5 (0%)

   

 IgG + IgA

Samples

4/63 (6.3%)

4/56 (7.1%)

0/5 (0%)

   

 IgM + IgA

Samples

6/63 (9.5%)

6/56 (10.7%)

0/5 (0%)

   

1-class reaction

Samples

13/63 (20.6%)

11/56 (19.6%)

1/5 (20%)

6/18 (33.3%)

3/16 (18.8%)

2/22 (9.1%)

 Only IgG

Samples

4/63 (6.3%)

3/56 (5.4%)

0/5 (0%)

   

 Only IgM

Samples

5/63 (7.9%)

5/56 (8.9%)

0/5 (0%)

   

 Only IgA

Samples

4/63 (6.3%)

3/56 (5.4%)

1/5 (20%)

   

b. Based on Ig-IF > 10%

3-class reactiona

Samples

2/63 (3.2%)

2/56 (3.6%)

0/5 (0%)

1/18 (5.6%)

0/16 (0%)

1/22 (4.5%)

2-class reactionb

Samples

6/63 (9.5%)

6/56 (10.7%)

0/5 (0%)

2/18 (11.1%)

1/16 (6.3%)

3/22 (13.6%)

 IgG + IgM

Samples

0/63 (0%)

0/56 (0%)

0/5 (0%)

   

 IgG + IgA

Samples

1/63 (1.6%)

1/56 (1.8%)

0/5 (0%)

   

 IgM + IgA

Samples

5/63 (7.9%)

5/56 (8.9%)

0/5 (0%)

   

1-class reaction

Samples

13/63 (20.6%)

13/56 (23.2%)

0/5 (0%)

9/18 (50%)

3/16 (18.8%)

1/22 (4.5%)

 Only IgG

Samples

3/63 (4.8%)

3/56 (5.4%)

0/5 (0%)

   

 Only IgM

Samples

6/63 (9.5%)

6/56 (10.7%)

0/5 (0%)

   

 Only IgA

Samples

4/63 (6.3%)

4/56 (7.1%)

0/5 (0%)

   
  1. aIF in samples with a three-class reaction: IgG-IF 10.18%, IgM-IF 71.35% and IgA-IF 48.89%; IgG-IF 26.97%, IgM-IF 53.58% and IgA-IF 11; respectively
  2. bIF in samples with a two-class reaction: IgM-IF 27.03% and IgA-IF 19.52%; IgG-IF 23.91% and IgA-IF 35.97%; IgM-IF 36.11% and IgA-IF 12.59%; IgM-IF 26.83% and IgA-IF 82.42%; IgG-IF 10.18% and IgM-IF 71.35%; IgM-IF 50.99% and IgA-IF 62.57%; IgM-IF 51.32% and IgA-IF 23.29%; IgG-IF 26.97% and IgM-IF 53%; respectively